Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease

Area of Science:

• Immunology
• Pediatric Rheumatology
• Vasculitis Research

Background:

• Kawasaki disease (KD) is a critical vasculitis in children, marked by a pro-inflammatory cytokine cascade.
• Understanding the immunological profile of KD is crucial for identifying disease mechanisms.
• Transforming growth factor-beta 1 (TGF-beta 1) is a key regulatory cytokine with immunomodulatory functions.

Purpose of the Study:

• To investigate the serum levels of TGF-beta 1 in patients with KD.
• To compare TGF-beta 1 levels in KD patients with those in patients with anaphylactoid purpura (AP) and scarlet fever.
• To explore the relationship between TGF-beta 1 and other inflammatory markers, such as soluble tumor necrosis factor (TNF) receptors, in KD.

Main Methods:

• Serum samples were collected from patients diagnosed with KD, AP, and scarlet fever during their acute stages.
• Concentrations of TGF-beta 1 were quantified using a sandwich enzyme-linked immunosorbent assay (ELISA).
• Serum levels of soluble TNF receptors were also measured to assess correlations with TGF-beta 1.

Main Results:

• Serum TGF-beta 1 levels were significantly decreased in patients during the acute stage of KD.
• No significant changes in serum TGF-beta 1 levels were observed in patients with AP or scarlet fever compared to controls.
• An inverse correlation was found between TGF-beta 1 levels and soluble TNF receptor levels in KD patients during both acute and subacute stages.

Conclusions:

• Decreased serum TGF-beta 1 levels are a characteristic feature of the acute stage of Kawasaki disease.
• Reduced TGF-beta 1 may impair its ability to suppress tumor necrosis factor alpha (TNF-alpha) production.
• This dysregulation in TGF-beta 1 may contribute to the heightened TNF-alpha activity and subsequent vasculitis observed in KD.